BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38732135)

  • 1. The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma.
    Castro-Ribeiro ML; Castro VIB; Vieira de Castro J; Pires RA; Reis RL; Costa BM; Ferreira H; Neves NM
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers.
    Erkoc P; Cingöz A; Onder TB; Kizilel S
    Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27762493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens.
    Pedron S; Wolter GL; Chen JE; Laken SE; Sarkaria JN; Harley BAC
    Biomaterials; 2019 Oct; 219():119371. PubMed ID: 31352310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells.
    Xiao W; Ehsanipour A; Sohrabi A; Seidlits SK
    J Vis Exp; 2018 Aug; (138):. PubMed ID: 30199037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform.
    Ananthanarayanan B; Kim Y; Kumar S
    Biomaterials; 2011 Nov; 32(31):7913-23. PubMed ID: 21820737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combined Influence of Hydrogel Stiffness and Matrix-Bound Hyaluronic Acid Content on Glioblastoma Invasion.
    Chen JE; Pedron S; Harley BAC
    Macromol Biosci; 2017 Aug; 17(8):. PubMed ID: 28379642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.
    Pedron S; Hanselman JS; Schroeder MA; Sarkaria JN; Harley BAC
    Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28766870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma.
    Xiao W; Wang S; Zhang R; Sohrabi A; Yu Q; Liu S; Ehsanipour A; Liang J; Bierman RD; Nathanson DA; Seidlits SK
    Matrix Biol; 2020 Jan; 85-86():128-146. PubMed ID: 31028838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of matrix metalloproteinase-mediated matrix degradation on glioblastoma cell behavior in 3D PEG-based hydrogels.
    Wang C; Tong X; Jiang X; Yang F
    J Biomed Mater Res A; 2017 Mar; 105(3):770-778. PubMed ID: 27770562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Hyaluronic Acid and Glioblastoma Cell Coculture on the Formation of Endothelial Cell Networks in Gelatin Hydrogels.
    Ngo MT; Harley BA
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility.
    Kim Y; Kumar S
    Mol Cancer Res; 2014 Oct; 12(10):1416-29. PubMed ID: 24962319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Synthetic, Injectable Hydrogel to Capture Residual Glioblastoma and Glioblastoma Stem-Like Cells with CXCL12-Mediated Chemotaxis.
    Khan ZM; Munson JM; Long TE; Vlaisavljevich E; Verbridge SS
    Adv Healthc Mater; 2023 Jun; 12(14):e2300671. PubMed ID: 37014179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
    Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
    Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin.
    Soteriadou KP; Remoundos MS; Katsikas MC; Tzinia AK; Tsikaris V; Sakarellos C; Tzartos SJ
    J Biol Chem; 1992 Jul; 267(20):13980-5. PubMed ID: 1629196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.
    Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ
    FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.